- Home
- GBCI vs LEGN Comparison
GBCI vs LEGN Comparison
Compare GBCI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBCI
- LEGN
- Stock Information
- Founded
- GBCI 1955
- LEGN 2014
- Country
- GBCI United States
- LEGN United States
- Employees
- GBCI 3457
- LEGN N/A
- Industry
- GBCI Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- GBCI Finance
- LEGN Health Care
- Exchange
- GBCI Nasdaq
- LEGN Nasdaq
- Market Cap
- GBCI 5.1B
- LEGN 5.4B
- IPO Year
- GBCI N/A
- LEGN 2020
- Fundamental
- Price
- GBCI $47.08
- LEGN $35.64
- Analyst Decision
- GBCI Buy
- LEGN Strong Buy
- Analyst Count
- GBCI 6
- LEGN 13
- Target Price
- GBCI $50.83
- LEGN $75.17
- AVG Volume (30 Days)
- GBCI 802.8K
- LEGN 2.0M
- Earning Date
- GBCI 07-17-2025
- LEGN 08-08-2025
- Dividend Yield
- GBCI 2.80%
- LEGN N/A
- EPS Growth
- GBCI 7.02
- LEGN N/A
- EPS
- GBCI 1.87
- LEGN N/A
- Revenue
- GBCI $827,816,000.00
- LEGN $728,303,000.00
- Revenue This Year
- GBCI $9.03
- LEGN $65.49
- Revenue Next Year
- GBCI $14.29
- LEGN $53.76
- P/E Ratio
- GBCI $25.19
- LEGN N/A
- Revenue Growth
- GBCI 8.47
- LEGN 112.46
- 52 Week Low
- GBCI $35.57
- LEGN $27.34
- 52 Week High
- GBCI $60.67
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- GBCI 71.49
- LEGN 57.79
- Support Level
- GBCI $42.68
- LEGN $32.42
- Resistance Level
- GBCI $43.98
- LEGN $36.91
- Average True Range (ATR)
- GBCI 1.09
- LEGN 1.42
- MACD
- GBCI 0.58
- LEGN 0.02
- Stochastic Oscillator
- GBCI 97.40
- LEGN 67.58
About GBCI Glacier Bancorp Inc.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.